Tag Archives: Michael Petusky

Barrington Remains a Hold on Haemonetics (HAE)

In a report released today, Michael Petusky from Barrington maintained a Hold rating on Haemonetics (HAE – Research Report). The company’s shares closed last Tuesday at $86.26. According to TipRanks.com, Petusky is a 4-star analyst with an average return of

The Providence Service (PRSC) Initiated with a Buy at Barrington

In a report released today, Michael Petusky from Barrington initiated coverage with a Buy rating on The Providence Service (PRSC – Research Report) and a price target of $104.00. The company’s shares closed last Tuesday at $88.09. According to TipRanks.com,

Landec (LNDC) Gets a Hold Rating from Barrington

Barrington analyst Michael Petusky maintained a Hold rating on Landec (LNDC – Research Report) today. The company’s shares closed last Wednesday at $9.65. According to TipRanks.com, Petusky is a 4-star analyst with an average return of 7.6% and a 51.2%

Barrington Maintains Their Buy Rating on US Physical Therapy (USPH)

In a report released today, Michael Petusky from Barrington maintained a Buy rating on US Physical Therapy (USPH – Research Report), with a price target of $100.00. The company’s shares closed last Friday at $90.68. According to TipRanks.com, Petusky is

Barrington Keeps a Buy Rating on SurModics (SRDX)

Barrington analyst Michael Petusky maintained a Buy rating on SurModics (SRDX – Research Report) today and set a price target of $63.00. The company’s shares closed last Wednesday at $48.48, close to its 52-week high of $48.94. According to TipRanks.com,

Analysts Are Bullish on These Healthcare Stocks: Opko Health (OPK), Synthetic Biologics (SYN)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Opko Health (OPK – Research Report) and Synthetic Biologics (SYN – Research Report) with bullish sentiments. Opko Health (OPK) Barrington analyst Michael